Recalls affecting Guam
Notices that name Guam in their distribution area, plus every nationwide recall — nationwide recalls reach Guam too.
-
Class I · 3 months ago
Abiomed Impella CP Set, Pump Set Code 0048-0003 recall: A potential for introducer sheath leakage from under the sheath cap and along
A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These…
-
Class II · 3 months ago
Boston Scientific Corporation Rapid Refill Continuous Injection System, UPN M00566001 recall: Devices contain recalled Medline Namic Angiographic Control Syringe
Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from…
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc Foster & Thrive, Carbamide Peroxide 6.5%, 0.5 FL OZ recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc Good Neighbor Pharmacy, Carbamide Peroxide 6.5%, 0.5 Fl Oz recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc Audiologist's Choice, Carbamide Peroxide 6.5% recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc TopCare Health, Carbamide Peroxide 6.5% recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc CVS Health, Carbamide Peroxide, 6.5%, 0.5 FL Oz , a) Bottle recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc meijer, Carbamide Peroxide 6.5%, 0.5 FL OZ recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Padagis US LLC Nystatin Cream USP recall: Subpotent Drug: Low out of specification assay results performed during
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc CAREone, Carbamide Peroxide 6.5%, 0.5 FL OZ , Bottle recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
CareFusion 213, LLC BD ChloraPrep Clear, and 70% v/v isopropyl alcohol) recall: Lack of Assurance of Sterility: Affected product may exhibit an open
Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc Family Wellness, Carbamide Peroxide 6.5%, 0.5 Fl Oz recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc Leader, Carbamide Peroxide 6.5%, 0.5 Fl Oz recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc Clinere, Carbamide Peroxide recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Bell Pharmaceuticals, Inc QC Quality Choice, Carbamide Peroxide, 6.5% recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
-
Class II · 3 months ago
Chiesi USA, Inc. Cleviprex 50 mg/100 mL , 10 Single Use Vials recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
NHTSA safety recall · 3 months ago
Ford Explorer and Lincoln Aviator recall: An unoccupied driver's seat may recline unintentionally during certain
An unoccupied driver's seat may recline unintentionally during certain scenarios, such as remote unlock or remote start.
-
Highest risk · 3 months ago
Target Cat & Jack Children's Sandals recall: Risk of Serious Injury or Death from Choking Hazard
Risk of Serious Injury or Death from Choking Hazard
-
Highest risk · 3 months ago
Panasonic Electric Toaster Ovens recall: Shock and Fire Hazards
Shock and Fire Hazards
-
Highest risk · 3 months ago
Madewell Women's Sweaters recall: Due to Risk of Serious Injury or Death from Burn Hazard
Due to Risk of Serious Injury or Death from Burn Hazard; Violate Mandatory Standard for Clothing Textiles
-
Highest risk · 3 months ago
Huish Outdoors Hollis Diving Regulators recall: Risk of Serious Injury or Death from Drowning
Risk of Serious Injury or Death from Drowning
-
Highest risk · 3 months ago
Currey & Company Nottaway Chandeliers recall: Risk of Serious Injury or Death from Electrocution Hazard
Risk of Serious Injury or Death from Electrocution Hazard
-
NHTSA safety recall · 3 months ago
Nissan Armada, Infiniti QX56 and and 2014-2027 QX80 recall: The Gross Axle Weight Rating (GAWR) listed on the certification label
The Gross Axle Weight Rating (GAWR) listed on the certification label is incorrect, which can allow the vehicle to be overloaded. As such, these…
-
Class II · 3 months ago
Integra LifeSciences Corp. OmniTract Surgical Retractor System recall: The current Omni-Tract Surgical Retractor System IFU states a dry time of 30
The current Omni-Tract Surgical Retractor System IFU states a dry time of 30 minutes. Integra LifeSciences has identified that the dry time needs to…